• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性全胃切除术用于携带胚系 CDH1 突变的个体。

Prophylactic total gastrectomy for individuals with germline CDH1 mutation.

机构信息

Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

出版信息

Surgery. 2011 Mar;149(3):347-55. doi: 10.1016/j.surg.2010.07.005. Epub 2010 Aug 17.

DOI:10.1016/j.surg.2010.07.005
PMID:20719348
Abstract

BACKGROUND

Germline mutation of the CDH1 gene, which encodes for the E-cadherin adhesion protein, is rare but confers an estimated lifetime risk of hereditary diffuse gastric cancer of 87%. Fewer than 100 prophylactic total gastrectomies have been reported for this condition.

METHODS

Patients with germline CDH1 mutation who underwent multidisciplinary counseling followed by prophylactic total gastrectomy were reviewed.

RESULTS

Ten patients (6 male, 4 female) with a median age of 42 years (range, 26-51) underwent prophylactic total gastrectomy between 2006 and 2009. Of the 6 families represented, there were 4 missense, 1 frameshift, and 1 splice site mutation. Median time from genetic testing to surgery was 3 months (range, 1-7). All patients had an upper endoscopy before surgery, identifying only 1 patient with a focus of diffuse gastric cancer. After prophylactic total gastrectomy, extensive pathologic analysis demonstrated that 9 patients had up to 77 foci of noninvasive cancer, and 2 of these patients had 4-12 foci of T1 invasive cancer. Median operative time was 213 minutes; there were no anastomotic leaks, and the length of stay was 7-8 days. One patient had a complication within 30 days (pulmonary embolism), and 3 patients had late complications (2 small bowel obstructions and 1 anastomotic stricture). Median weight loss at 6 months was 19%.

CONCLUSION

The majority of patients with germline CDH1 mutation have foci of noninvasive or invasive gastric cancer by middle age. Serial upper endoscopies provide inadequate screening. Prophylactic total gastrectomy is the procedure of choice for definitive treatment.

摘要

背景

CDH1 基因的胚系突变,该基因编码 E-钙黏蛋白黏附蛋白,较为罕见,但估计遗传性弥漫性胃癌的终身风险为 87%。据报道,这种情况下只有不到 100 例预防性全胃切除术。

方法

对接受多学科咨询后行预防性全胃切除术的 CDH1 胚系突变患者进行回顾性分析。

结果

10 例(6 男 4 女)患者的中位年龄为 42 岁(范围 26-51),于 2006 年至 2009 年间行预防性全胃切除术。所代表的 6 个家族中,有 4 个错义突变、1 个移码突变和 1 个剪接位点突变。基因检测到手术的中位时间为 3 个月(范围 1-7)。所有患者术前均行上消化道内镜检查,仅发现 1 例弥漫性胃癌病灶。行预防性全胃切除术后,广泛的病理分析显示 9 例患者有多达 77 个非浸润性癌灶,其中 2 例患者有 4-12 个 T1 浸润性癌灶。中位手术时间为 213 分钟;无吻合口漏,住院时间为 7-8 天。1 例患者术后 30 天内发生并发症(肺栓塞),3 例患者发生晚期并发症(2 例小肠梗阻和 1 例吻合口狭窄)。6 个月时的中位体重减轻为 19%。

结论

大多数 CDH1 基因胚系突变患者中年时会出现非浸润性或浸润性胃癌病灶。连续上消化道内镜检查提供的筛查不足。预防性全胃切除术是明确治疗的首选方法。

相似文献

1
Prophylactic total gastrectomy for individuals with germline CDH1 mutation.预防性全胃切除术用于携带胚系 CDH1 突变的个体。
Surgery. 2011 Mar;149(3):347-55. doi: 10.1016/j.surg.2010.07.005. Epub 2010 Aug 17.
2
Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome.遗传性弥漫性胃癌综合征的预防性胃切除术
J Am Coll Surg. 2006 Apr;202(4):612-7. doi: 10.1016/j.jamcollsurg.2005.12.017.
3
Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.针对E-钙黏蛋白(CDH1)种系突变进行的降低风险的全胃切除术:具有临床意义的病理结果
Am J Surg Pathol. 2008 Jun;32(6):799-809. doi: 10.1097/PAS.0b013e31815e7f1a.
4
CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.E-钙黏蛋白基因中的CDH1截短突变:全胃切除术治疗遗传性弥漫性胃癌的指征
Ann Surg. 2007 Jun;245(6):873-9. doi: 10.1097/01.sla.0000254370.29893.e4.
5
Prophylactic total gastrectomy for familial gastric cancer.家族性胃癌的预防性全胃切除术
Surgery. 2001 Oct;130(4):612-7; discussion 617-9. doi: 10.1067/msy.2001.117099.
6
Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.遗传性弥漫性胃癌:基因检测对筛查和预防性手术的意义
Cancer. 2008 Oct 1;113(7 Suppl):1850-6. doi: 10.1002/cncr.23650.
7
Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.三个晚期胃癌家系中 E-钙黏蛋白基因胚系突变:对其他家族成员的临床影响。
Eur J Gastroenterol Hepatol. 2010 Mar;22(3):306-10. doi: 10.1097/MEG.0b013e32832bab9a.
8
CDH1 associated gastric cancer: a report of a family and review of the literature.CDH1相关的胃癌:一个家族报告及文献综述
Eur J Surg Oncol. 2005 Apr;31(3):259-64. doi: 10.1016/j.ejso.2004.12.010.
9
[From gene to disease; E-cadherin and hereditary diffuse gastric cancer].从基因到疾病;E-钙黏蛋白与遗传性弥漫性胃癌
Ned Tijdschr Geneeskd. 2003 Dec 13;147(50):2474-7.
10
[Preventive resection of hereditary diffuse gastric cancer].遗传性弥漫性胃癌的预防性切除
Ned Tijdschr Geneeskd. 2006 Nov 4;150(44):2417-20.

引用本文的文献

1
A Systematic Review on Clinical and Health-Related Quality of Life Outcomes following Total Gastrectomy in Patients with Hereditary Diffuse Gastric Cancer.遗传性弥漫性胃癌患者全胃切除术后临床及健康相关生活质量结局的系统评价
Cancers (Basel). 2024 Jan 23;16(3):473. doi: 10.3390/cancers16030473.
2
Pioneering use of genetic analysis for to identify candidates for prophylactic total gastrectomy to prevent hereditary diffuse gastric cancer.开创性地利用基因分析来识别预防性全胃切除术的候选者,以预防遗传性弥漫性胃癌。
eGastroenterology. 2023 Sep;1(2). doi: 10.1136/egastro-2023-100017. Epub 2023 Dec 9.
3
Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers.
针对CDH1基因携带者的腹腔镜预防性全胃切除术及有限淋巴结清扫术
Surg Endosc. 2023 Dec;37(12):9373-9380. doi: 10.1007/s00464-023-10303-7. Epub 2023 Aug 29.
4
Surgical Management of Germline Gastrointestinal Stromal Tumor.胚系胃肠道间质瘤的外科治疗。
Ann Surg Oncol. 2023 Aug;30(8):4966-4974. doi: 10.1245/s10434-023-13519-y. Epub 2023 Apr 28.
5
Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations.与胚系 CDH1 突变个体内镜下检测遗传性弥漫性胃癌相关的因素。
Gastrointest Endosc. 2023 Sep;98(3):326-336.e3. doi: 10.1016/j.gie.2023.04.2071. Epub 2023 Apr 23.
6
E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer.E-钙黏蛋白是弥漫型胃癌铁死亡敏感性的生物标志物。
Oncogene. 2023 Mar;42(11):848-857. doi: 10.1038/s41388-023-02599-5. Epub 2023 Jan 30.
7
Hereditary Diffuse Gastric Cancer: A 2022 Update.遗传性弥漫性胃癌:2022年最新进展
J Pers Med. 2022 Dec 8;12(12):2032. doi: 10.3390/jpm12122032.
8
Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene.54 例 CDH1 种系致病性突变患者行预防性全胃切除术的近期和远期结局。
J Surg Oncol. 2022 Dec;126(8):1413-1422. doi: 10.1002/jso.27084. Epub 2022 Sep 5.
9
Primary and metastatic peritoneal surface malignancies.原发性和转移性腹膜表面恶性肿瘤。
Nat Rev Dis Primers. 2021 Dec 16;7(1):91. doi: 10.1038/s41572-021-00326-6.
10
Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation.基因突变遗传性弥漫性胃癌的预后:大型队列分析、内镜监测的系统评价及继发癌症风险推测
Cancers (Basel). 2021 May 26;13(11):2622. doi: 10.3390/cancers13112622.